28 results
Keyword Armisarte Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis)
pemetrexed diacid monohydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016, Revision: 12, Authorised, Last updated: 18/01/2023Armisarte (previously Pemetrexed Actavis) Cancer Neoplasms Carcinoma … Armisarte (previously Pemetrexed Actavi … summary for the public Armisarte1 pemetrexed This is a summary … -
List item
News: Clinical data for two more medicines now available online
Last updated: 24/11/2016Armisarte … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited)
pemetrexed ditromethamine, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 24/04/2017,
, Revision: 7, Withdrawn, Last updated: 29/07/2021
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 November 2015
Last updated: 20/11/2015application/pdf Organisational matters Armisarte (previously Pemetrexed Actavis … -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2022
Written procedure, from 16/08/2022 to 19/08/2022, Last updated: 04/10/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
Parallel distribution: Regulatory and procedural guidance
Last updated: 09/06/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 27/09/2021 to 30/09/2021, Last updated: 27/02/2018 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 17/03/2023 -
List item
Update on the implementation of policy on publication of clinical data (Policy 0070) – Industry associations webinar
European Medicines Agency, London, UK, 29/06/2017, Last updated: 05/07/2017Kyprolis 20 October 2016 115 Armisarte 23 November 2016 19 Caspofungin … -
List item
Support for industry on clinical data publication
Last updated: 16/09/2020 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 27/03/2023 -
List item
Update on the implementation of EMA policy on publication of clinical data (Policy 0070) and draft revisions guidance to industry - industry associations webinar
European Medicines Agency, London, UK, 23/03/2017, Last updated: 31/03/2017October 2016 115 75,000 0 3 Armisarte 23 November 2016 19 95 6 … -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2017
European Medicines Agency, London, UK, from 23/01/2017 to 26/01/2017, Last updated: 06/01/2014 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021
PRAC, Last updated: 01/10/2021 -
List item
News: EMA's proactive publication of clinical data a success
Last updated: 16/07/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 September 2018
European Medicines Agency, London, UK, from 17/09/2018 to 20/09/2018, Last updated: 31/10/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 15-18 May 2017
European Medicines Agency, London, UK, from 15/05/2017 to 18/05/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 April 2017
European Medicines Agency, London, UK, from 18/04/2017 to 21/04/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-28 June 2018
European Medicines Agency, London, UK, from 25/06/2018 to 28/06/2018, Last updated: 06/01/2014 -
List item
Update on the implementation of EMA policy on publication of clinical data (Policy 0070) and draft revisions to the guidance to industry – industry associations webinar
European Medicines Agency, London, UK, 09/12/2016, Last updated: 09/12/2016October 2016 115 75,000 0 Armisarte 23 November 2016 19 95 … -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 March 2017
European Medicines Agency, London, UK, from 20/03/2017 to 23/03/2017, Last updated: 20/03/2017 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 12-15 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 12/12/2022 to 15/12/2022, Last updated: 06/04/2021